Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis
about
Recent progress in the study of methylated tumor suppressor genes in gastric cancerDynamic aberrant NF-κB spurs tumorigenesis: a new model encompassing the microenvironmentO-GlcNAcylation and Metabolic Reprograming in CancerThe expression of glyceraldehyde-3-phosphate dehydrogenase associated cell cycle (GACC) genes correlates with cancer stage and poor survival in patients with solid tumorsPromoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancerXmrk, kras and myc transgenic zebrafish liver cancer models share molecular signatures with subsets of human hepatocellular carcinomaGlucose-induced metabolic memory in Schwann cells: prevention by PPAR agonists.FBP1 expression is associated with basal-like breast carcinomaZIC1 is downregulated through promoter hypermethylation, and functions as a tumor suppressor gene in colorectal cancerInterplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approachesEvaluation of the suitability of archival Bouin-fixed paraffin-embedded tissue specimens to proteomic investigation.The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanismPrediction of gastric cancer metastasis through urinary metabolomic investigation using GC/MS.CpG methylation recruits sequence specific transcription factors essential for tissue specific gene expressionSuppression of gluconeogenic gene expression by LSD1-mediated histone demethylation.Genes dysregulated to different extent or oppositely in estrogen receptor-positive and estrogen receptor-negative breast cancers.Klotho is silenced through promoter hypermethylation in gastric cancer.Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer.From inflammaging to healthy aging by dietary lifestyle choices: is epigenetics the key to personalized nutrition?ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferationHomeobox D10 gene, a candidate tumor suppressor, is downregulated through promoter hypermethylation and associated with gastric carcinogenesis.Overexpression of metabolic markers HK1 and PKM2 contributes to lymphatic metastasis and adverse prognosis in Chinese gastric cancer.Emerging glycolysis targeting and drug discovery from chinese medicine in cancer therapy.Ion chromatography based urine amino Acid profiling applied for diagnosis of gastric cancer.Downregulation of FBP1 Promotes Tumor Metastasis and Indicates Poor Prognosis in Gastric Cancer via Regulating Epithelial-Mesenchymal Transition.NPM1 activates metabolic changes by inhibiting FBP1 while promoting the tumorigenicity of pancreatic cancer cells.Dose-dependent effects of calorie restriction on gene expression, metabolism, and tumor progression are partially mediated by insulin-like growth factor-1Oncogenic Ras suppresses ING4-TDG-Fas axis to promote apoptosis resistance.3-bromopyruvate and sodium citrate target glycolysis, suppress survivin, and induce mitochondrial-mediated apoptosis in gastric cancer cells and inhibit gastric orthotopic transplantation tumor growth.Association between FBP1 and hypoxia-related gene expression in clear cell renal cell carcinomaLoss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer.The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasisRemodelling of the hepatic epigenetic landscape of glucose-intolerant rainbow trout (Oncorhynchus mykiss) by nutritional status and dietary carbohydratesDecreased fructose-1,6-bisphosphatase-2 expression promotes glycolysis and growth in gastric cancer cells.The genome-wide expression profile of 1,2,3,4,6-penta-O-galloyl-β-D-glucose-treated MDA-MB-231 breast cancer cells: molecular target on cancer metabolism.Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression.Repurposing the anti-malarial drug dihydroartemisinin suppresses metastasis of non-small-cell lung cancer via inhibiting NF-κB/GLUT1 axis.The metabolic switch and its regulation in cancer cells.Epigenetic-mediated tumor suppressor genes as diagnostic or prognostic biomarkers in gastric cancer.Regulation and function of mitophagy in development and cancer.
P2860
Q27009359-253E02F8-A4DC-49D5-82A7-C98EDBB33974Q27025321-5BA8A1E4-A691-42C1-8E83-76825D47B894Q27027028-43DB18F6-2979-45E9-81FE-97AFBBD8E716Q28289698-A4546E59-76BC-49DC-8AD2-6870EEEAA420Q28477572-46FAE011-5D87-41DD-B519-CE0EF59E59A8Q28540910-D767CC61-7060-45EC-9587-7CD04C32081AQ33569693-0D8FB897-E2B6-429A-94A3-DE2AAF7B8312Q33686009-547ADC13-A2F2-4E80-9D78-C0174FE1DF49Q33828288-4D2236F9-B988-45DA-A609-45CABC2B768FQ33835913-DB145419-2DF1-4A2B-9E58-DD371514A8E3Q34287040-B75C638E-7943-42F5-A9AF-ECCF059005B4Q34332654-40926977-F540-4DA5-B507-7D7AA3F313FDQ34591157-58B762C6-5AFD-460F-A71B-4A281D23F094Q34636402-9E9801E9-D52C-4FD7-92D7-C4BD381B96CFQ34766859-91B42A9A-FC55-4777-8FBE-EF434CE20FC5Q34854816-3F4B7C01-508A-4FE6-AA9F-82B73036504BQ35232389-3F363E46-4E95-4F53-8B31-7F27AFF175E8Q35313220-9C982141-E905-4409-BDA2-1282261EDA28Q35314161-F53E7BCF-1231-4C0E-9360-7EEBAAE194C8Q35899955-14E5D74E-48FC-42D6-BE9D-BF263F9BBBE1Q35973274-C8A36D96-83B8-4E0C-8E1A-50EC3D9060DBQ36095239-4B4DA89E-5C34-4993-87B8-F029FE918689Q36111593-2F48109C-D2DE-44AC-9DB7-CB8B00539C2FQ36135050-9420AA54-3C79-45F2-9024-432876ACE1C0Q36225499-905B76D9-BC1A-4B71-AC9F-8986D92E7254Q36356360-6EBB1E05-191B-42C4-9A2B-35DFD179F545Q36530674-83C2E981-B863-45F0-8B70-362573B76D57Q36561651-8859F28A-755C-4FD9-93CE-1BCBFA1FAC76Q36572127-C97FE0B9-CDC9-4CDE-8A06-8C9E8E188051Q36954700-2D725EEA-76DE-46BF-813A-92C6C1DC777DQ36989021-3BF50772-849F-4601-B8B1-740B29167363Q37179521-38DACAA0-2764-49A3-9FEC-44BFDE057C7FQ37209146-42A30A6E-21B3-4284-8F6A-E3EBB7EB96F0Q37360758-6718E5F2-C523-4D18-8A7F-0817736F9E4AQ37461264-96C8CE79-C671-49F7-94F3-1AF075A045C3Q37682212-035617A8-F145-4894-9D71-DE21763750A8Q37699414-D427855D-981B-4677-B1FA-BA2859525197Q37785870-6A8605C1-FC0E-47E3-A8CC-47DEC8458461Q38115621-F8DB7984-93C9-4A1E-A3A5-24C502F16CAAQ38148991-E492905D-8F85-470D-A2CC-5FAED18195ED
P2860
Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Warburg effect revisited: an e ...... sis and gastric carcinogenesis
@ast
Warburg effect revisited: an e ...... sis and gastric carcinogenesis
@en
Warburg effect revisited: an e ...... sis and gastric carcinogenesis
@en-gb
Warburg effect revisited: an e ...... sis and gastric carcinogenesis
@nl
type
label
Warburg effect revisited: an e ...... sis and gastric carcinogenesis
@ast
Warburg effect revisited: an e ...... sis and gastric carcinogenesis
@en
Warburg effect revisited: an e ...... sis and gastric carcinogenesis
@en-gb
Warburg effect revisited: an e ...... sis and gastric carcinogenesis
@nl
prefLabel
Warburg effect revisited: an e ...... sis and gastric carcinogenesis
@ast
Warburg effect revisited: an e ...... sis and gastric carcinogenesis
@en
Warburg effect revisited: an e ...... sis and gastric carcinogenesis
@en-gb
Warburg effect revisited: an e ...... sis and gastric carcinogenesis
@nl
P2093
P2860
P50
P921
P3181
P356
P1433
P1476
Warburg effect revisited: an e ...... sis and gastric carcinogenesis
@en
P2093
P2860
P2888
P304
P3181
P356
10.1038/ONC.2009.332
P407
P577
2009-11-02T00:00:00Z
P5875
P6179
1049302543